Kubota Pharmaceutical Holdings Co., Ltd. Logo

Kubota Pharmaceutical Holdings Co., Ltd.

A clinical-stage company developing drugs and devices for ophthalmic diseases.

4596 | T

Overview

Corporate Details

ISIN(s):
JP3266500002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目7番1号

Description

Kubota Pharmaceutical Holdings Co., Ltd., through its subsidiary Kubota Vision Inc., is a clinical-stage company dedicated to developing novel treatments for ophthalmic diseases. Its mission is to translate scientific innovation into a diverse portfolio of drugs and devices to preserve and restore vision for people worldwide. The company's development pipeline features emixustat hydrochloride, a therapeutic candidate for Stargardt disease. In the device segment, Kubota is commercializing Kubota Glass®, a wearable technology designed to manage myopia. The company focuses on creating solutions to address the root causes of blindness and vision impairment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-11 07:42
確認書
Japanese 8.5 KB
2022-11-11 07:41
四半期報告書-第8期第3四半期(令和4年7月1日-令和4年9月30日)
Japanese 232.4 KB
2022-08-12 08:03
確認書
Japanese 8.4 KB
2022-08-12 08:01
四半期報告書-第8期第2四半期(令和4年4月1日-令和4年6月30日)
Japanese 198.0 KB
2022-05-13 08:02
四半期報告書-第8期第1四半期(令和4年1月1日-令和4年3月31日)
Japanese 178.7 KB
2022-03-29 08:19
内部統制報告書-第7期(令和3年1月1日-令和3年12月31日)
Japanese 22.6 KB
2022-03-29 08:18
有価証券報告書-第7期(令和3年1月1日-令和3年12月31日)
Japanese 780.3 KB
2022-03-29 08:18
確認書
Japanese 8.3 KB
2021-11-12 07:03
四半期報告書-第7期第3四半期(令和3年7月1日-令和3年9月30日)
Japanese 196.5 KB
2021-08-12 08:05
四半期報告書-第7期第2四半期(令和3年4月1日-令和3年6月30日)
Japanese 198.4 KB
2021-05-13 08:03
四半期報告書-第7期第1四半期(令和3年1月1日-令和3年3月31日)
Japanese 184.4 KB
2021-03-30 04:32
内部統制報告書-第6期(令和2年1月1日-令和2年12月31日)
Japanese 22.8 KB
2021-03-29 08:50
確認書
Japanese 8.4 KB
2021-03-29 08:49
有価証券報告書-第6期(令和2年1月1日-令和2年12月31日)
Japanese 813.1 KB
2020-11-13 07:01
四半期報告書-第6期第3四半期(令和2年7月1日-令和2年9月30日)
Japanese 242.6 KB

Automate Your Workflow. Get a real-time feed of all Kubota Pharmaceutical Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kubota Pharmaceutical Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kubota Pharmaceutical Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.